Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients

NCT04680039 is registered in ClinicalTrials.gov with Biobeat Technologies Ltd. as lead sponsor.

NCT NCT04680039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04680039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Hemodynamic Parameters Measurements as a Tool for Early Warning of Intradialytic Hypotension in Hemodialysis Patients
Lead sponsor
Biobeat Technologies Ltd.
Phase
Observational
Overall status
Completed
Start date
January 15, 2021
Completion date
March 15, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension of hemodialysis